Next Article in Journal
A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes
Previous Article in Journal
Protective Effects of Plant-Based Diets Against Colorectal Carcinogenesis via Modulation of Key Cellular and Molecular Mechanisms: A Comprehensive Review of Evidence
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 33
Issue 4
10.3390/curroncol33040223
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Reply published on 27 April 2026, see Curr. Oncol. 2026, 33(5), 248.
Comment of Curr. Oncol. 2026, 33(2), 89.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89

by
Janhavi Venkataraman
* and
Kefah Mokbel
The London Breast Institute, Princess Grace Hospital, HCA Healthcare Private Limited, London W1U 5NY, UK
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2026, 33(4), 223; https://doi.org/10.3390/curroncol33040223
Submission received: 27 February 2026 / Accepted: 16 April 2026 / Published: 17 April 2026
(This article belongs to the Section Breast Cancer)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Sae-sim et al [...]

Share and Cite

MDPI and ACS Style

Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89. Curr. Oncol. 2026, 33, 223. https://doi.org/10.3390/curroncol33040223

AMA Style

Venkataraman J, Mokbel K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89. Current Oncology. 2026; 33(4):223. https://doi.org/10.3390/curroncol33040223

Chicago/Turabian Style

Venkataraman, Janhavi, and Kefah Mokbel. 2026. "Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89" Current Oncology 33, no. 4: 223. https://doi.org/10.3390/curroncol33040223

APA Style

Venkataraman, J., & Mokbel, K. (2026). Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89. Current Oncology, 33(4), 223. https://doi.org/10.3390/curroncol33040223

Article Metrics

Back to TopTop